<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01477996</url>
  </required_header>
  <id_info>
    <org_study_id>FR-7-CI-2011</org_study_id>
    <nct_id>NCT01477996</nct_id>
  </id_info>
  <brief_title>Pain After Intravitreal Therapy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial is comparing two different needles (27 gauge versus 30 gauge)&#xD;
      for intravitreal therapy (IVT). Standardized questionnaires and pain scales should allow for&#xD;
      standard recommendation regarding the optimal needle size for IVT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: To evaluate the influence of the type of the needle on pain scores after&#xD;
      intravitreal therapy (IVT).&#xD;
&#xD;
      Design: Randomized clinical trial Methods: A total of 200 patients, treated with an IVT for&#xD;
      exudative age-related macular degeneration (AMD) or a vascular retinal disease, will be&#xD;
      included and randomly assigned to be treated with either a 27-gauge needle (group 1) or a&#xD;
      30-gauge needle (group 2). After IVt the patient has to fill out a standardized questionnaire&#xD;
      including pain scores on the visual analog scale after the surgical procedure.&#xD;
&#xD;
      Regression analysis of the scaled questionnaires should allow for a standard recommendation&#xD;
      regarding the optimal needle size for minimal subjective pain during IVT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analoge Scale</measure>
    <time_frame>1 day, after the intravitreal therapy (IVT)</time_frame>
    <description>pain scores on the visual analog scale after the IVT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patients demographic data</measure>
    <time_frame>1 day, record of patients data before or after intravitreal therapy (IVT)</time_frame>
    <description>age, gender, number of IVT, surgeon, prior surgical procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baker scale</measure>
    <time_frame>1 day, after the intravitreal therapy (IVT)</time_frame>
    <description>pain scores on the baker scale after the IVT</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>27-gauge needle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30-gauge needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>27-gauge</intervention_name>
    <description>27-gauge needle for IVT</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>30-gauge</intervention_name>
    <description>30-gauge needle for IVT</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  vitrearetinal disease including age-related macular degeneration,&#xD;
&#xD;
          -  clinical significant macular edema due to diabetic retinopathy or other vascular&#xD;
             disorders&#xD;
&#xD;
          -  treatment with intravitreal therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  missing informed consent&#xD;
&#xD;
          -  age under 50 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>51 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christiane I Falkner-Radler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susanne Binder, MD</last_name>
    <role>Study Chair</role>
    <affiliation>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery, Department of Ophthalmology; Rudolf Foundation Clinic, Juchgasse 25</name>
      <address>
        <city>Vienna</city>
        <zip>1030</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <study_first_submitted>August 8, 2011</study_first_submitted>
  <study_first_submitted_qc>November 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2011</study_first_posted>
  <last_update_submitted>January 24, 2016</last_update_submitted>
  <last_update_submitted_qc>January 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</investigator_affiliation>
    <investigator_full_name>Dr. Christiane I. Falkner-Radler</investigator_full_name>
    <investigator_title>Principial investigator</investigator_title>
  </responsible_party>
  <keyword>intravitreal therapy</keyword>
  <keyword>pain scales</keyword>
  <keyword>gauge</keyword>
  <keyword>Pain Scores</keyword>
  <keyword>Visual Analog Scale</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

